PRIMARY STUDY
Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review
Key Findings: More research is needed, but this narrative review discusses the potential clinical indications for the use of cannabidiol, safety and efficacy parameters, and the current challenges in the quality and composition of various cannabis-based medical products available on the market.
Type of Study: Meta-analysis
Study Sample Size: 1
Study Result: Positive
Research Location(s): Brazil
Year of Pub: 2025
Cannabinoids Studied: Cannabichromene (CBC), Cannabidiol (CBD), Cannabigerol (CBG), Tetrahydrocannabinol (THC), Cannabinol (CBN), Cannabidiolic Acid (CBD-a), Synthetic Cannabinoid (unspecified), Pharma THC, Pharma THC:CBD, Pharma CBD, Tetrahydrocannabivarin (THCV), Delta-8-THC, Cannabidivarin (CBDV), Cannabitriol (CBT)
Phytocannabinoid Source: Not Applicable
Citation: Simei JLQ, Souza JDR, Pedrazzi JF, Guimarães FS, Campos AC, Zuardi A, Hallak JEC, Crippa JAS. Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review. Pharmaceuticals (Basel). 2024 Dec 6;17(12):1644. doi: 10.3390/ph17121644. PMID: 39770486; PMCID: PMC11677192.
